Evidence map›Paper›PMID 26588186›Full record

ReviewAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2016

Humanized Mouse Models for Transplant Immunology.

L L Kenney, L D Shultz, D L Greiner, M A Brehm

Abstract readReview
In one paragraph

Review in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. CD25Frontiers in immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Animal models for transplant immunology: bridging bench to bedside.Clinical transplantation and research · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Fetal liver CD34Stem cell research & therapy · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Emerging technologies and ethics-exogenic chimeric humanized organs.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

L L KenneyDepartment of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA.
L D ShultzThe Jackson Laboratory, Bar Harbor, ME.
D L GreinerDepartment of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA.
M A BrehmDepartment of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA.

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Development and Validation of Novel NSG Mouse Models for Human Stem Cell TherapyR24OD018259 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, GREINER, DALE LESLIE · 2014 to 2017
$3.0M
NCI NIH HHS P30 CA034196NIH HHS R24 OD018259
6 · The paper itself

Abstract

Our understanding of the molecular pathways that control immune responses, particularly immunomodulatory molecules that control the extent and duration of an immune response, have led to new approaches in the field of transplantation immunology to induce allograft survival. These molecular pathways are being defined precisely in murine models and translated into clinical practice; however, many of the newly available drugs are human-specific reagents. Furthermore, many species-specific differences exist between mouse and human immune systems. Recent advances in the development of humanized mice, namely, immunodeficient mice engrafted with functional human immune systems, have led to the availability of a small animal model for the study of human immune responses. Humanized mice represent an important preclinical model system for evaluation of new drugs and identification of the mechanisms underlying human allograft rejection without putting patients at risk. This review highlights recent advances in the development of humanized mice and their use as preclinical models for the study of human allograft responses.

Indexed as

Disease Models, AnimalOrgan TransplantationTransplantation ImmunologyAnimalsGraft RejectionHumansMicePrognosisanimal modelsbasic (laboratory) research/sciencecellular transplantation (non-islet)experimentalislet transplantationregenerative medicinerejectionstem cellstolerancetranslational research/science

Identifiers

PMID26588186
PMCPMC5283075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.